Canadian Task Force on Preventive Health Care

Selected References

Preventive Health Care, 2001 Update: Prevention of Early-onset Group B Streptococcal (GBS) Infection in the Newborn

Prepared by V. Shah, MD, MRCP, and A. Ohlsson, MD, MSc, FRCPC, FAAP, with the Canadian Task Force on Preventive Health Care

These recommendations were finalized by the Task Force in February 2001.

  1. Ablow RC, Driscoll SG, Effmann EL Gross I, Jolles CJ, Uauy R, Warshaw JB. A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn. N Engl J Med 1976;294:65-70.

  2. Adams WG, Kinney JS, Schuchat A, Collier CL, Papasian CJ et al. Outbreak of early  onset group B streptococcal sepsis. Pediatr Infect Dis J 1993;12:565-70.

  3. Allardice JG, Baskett TF, Seshia MM, Bowman N, Malazdrewicz R. Perinatal group B streptococcal colonization and infection. Am J Obstet Gynecol 1982;142:617-20.

  4. Almuneef M, Alalola S, Ahmed S, Memish Z, Khan MY, Alshaalan M. The changing pattern of group B streptococcal (GBS) infection in infants of Saudi Arabia. J Chemother 2000;12:48-52.

  5. Altaie SS, Dryja D. Detection of group B Streptococcus. Comparison of solid and liquid  culture medium with and without selective antibiotics. Diagn Microbiol Infect Dis  1994;18:141-4.

  6. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis. Pediatrics 1992;90:775-8.

  7. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.

  8. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy: ACOG’s recommendations. ACOG Newsletter 1993;37:1.

  9. Anthony BF, Eisenstadt R, Carter J, Kim KS, Hobel CJ. Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis 1981;143:761-6.

  10. Badri MS, Zawaneh S, Cruz AC, Mantilla G, Baer H, Spellacy WN, Ayoub EM. Rectal  colonization with group B streptococcus: relation to vaginal colonization in pregnant women. J Infect Dis 1977;135:308-12.

  11. Baker CJ, Clark DJ, Barrett FF. Selective broth medium for isolation of group B  streptococci. Appl Microbiol 1973;26:884-5.

  12. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein JO, eds. Infectious Disease of the Fetus and Newborn Infant. 4th ed. Philadelphia:WB Saunders. 1995:980-1054.

  13. Baker CJ, Goroff DK, Alpert S et al. Vaginal colonization with group B streptococcus: a  study of college women. J Infect Dis 1977;135:392-7.

  14. Baker CJ. Group B streptococcal infections. Clin Perinatol 1997;24:59-70.

  15. Beardsall K, Thompson MH, Mulla RJ. Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998. Arch Dis Child 2000:82:205-7.

  16. Bergeron MG, Danding KE, Menard C, Picard FJ, Gagnon M, Bernier M et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000;343:175-9.

  17. Berkowitz K, Regan JA, Greenberg E. Antibioitic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 1990;28:5-7.

  18. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal and early- onset disease. I. Epidemiologic Rationale. J Infect Dis 1983;148:795-801.

  19. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive  value of prenatal cultures. J Infect Dis 1983;148:802-9.

  20. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983;148:810-6.

  21. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcus disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.

  22. Bramer S, van Wijk FH, Mol BW, Adriaanse AH. Risk indicators for neonatal early-onset  GBS-related disease. A case-control study. J Perinat Med 1997;25:469-75.

  23. Carstensen H, Christensen KK, Grennet L, Persson K, Polberger S. Early-onset  neonatal group B septicemia in siblings. J Infect 1988;17:201-4.

  24. Centers for Disease Control and Prevention. Decreasing the incidence of perinatal  group B streptococcal disease- United States, 1993-95. MMWR 1997;46:473-7.

  25. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR 1996;45:1-24.

  26. Citernesi A, Formica G, Caruso S, Curiel P. Vaginal colonization of streptococcus B in pregnancy. Minerva Ginecol 1996;48:227-33.

  27. Davies HD, Raj S, Adair C, Robinson J, McGeer A, Group TA. Population-based active surveillance for neoantal group B streptococcal infections in Alberta: implications for vaccine formulation. Pediatr Infect Dis J 2001;20:879-84.

  28. Dillon HC Jr, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B  streptococci during pregnancy. J Infect Dis 1982;145:794-9.

  29. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31-6.

  30. Easmon CS, Hastings MJ, Deeley J, Bloxham B, Rivers RP, Marwood R. The effect of intrapartum chemoprophylaxis on the vertical transmissiom of group B streptococci. Br J Obstet Gynecol 1983;90:633-5.

  31. Eickhoff TC, Klein JO, Daly K, et al. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N Engl J Med 1964;271:1221-8.

  32. Fargason CA Jr, Peralta-Carcelen M, Rouse DJ, Cutter GR, Goldenberg RL. The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 1997;90:347-52.

  33. Faxelius G, Bremme K, Kvist-Christensen K, Christensen P, Ringertz S. Neonatal  septicemia due to group B streptococci- perinatal risk factors and outcome of  subsequent pregnancies. J Perinat Med 1988;16:423-30.

  34. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-9.

  35. Ferrieri P, Blair LL. Pharyngeal carriage of group B streptococci: detection by three  methods. J Clin Microbiol 1977;6:136-9.

  36. Food and Drug Administration (US). FDA safety alert: risks of devices for direct  detection of group B streptococcal antigen. Rockville (MD): Dept. of Health and Human  Services (US); 1997.

  37. Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust NZ J Obstet Gynecol 1991;31:119-22.

  38. Gibbs RS, McDuffie RS Jr, McNabb F, Fryer GE, Miyoshi T, Merenstein G. Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet Gynecol 1994;84:496-500.

  39. Goldenberg E, Davies HD, Landry L, The Toronto GBS study group. Hospital prevention policies and the incidence of early onset neonatal group B streptococcal disease. Abstract presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998;No.1879.

  40. Gordon JS, Sbarra AJ. Incidence, technique of isolation, and treatment of group B streptococci in obstetric patients. Am J Obstet Gynecol 1976;126:1023-6.

  41. Gotoff SP, Boyer KM. Prevention of early-onset neonatal group B streptococcal disease. Pediatrics 1997;99:866-9.

  42. Greenspoon JS, Fishman A, Wilcox JG, Greenspoon RL, Lewis W. Comparison of culture for group B streptococcus.versus enzyme immunoassay and latex agglutination rapid tests: results in 250 patients during labor. Obstet Gynecol 1991;77:97-100.

  43. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B  streptococcal colonization. Pediatrics 1999;104:203-9.

  44. Ho MY, Wu CT, Ku YT, Huang FY, Peng CC. Group B streptococcal infection in neonates: an 11-year review. Taiwan Erh Ko I Hsueh Hui Tsa Chih 1999;40:83-6.

  45. Idsoe O, Guthe T, Willcox RR, de Weck AL. Nature and scope of adverse effects of penicillin with special reference to 151 deaths following anaphylactic shock. Schweiz Med Wochenschr 1969;99:1221-9.

  46. Isaacs D, Royle JA. Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J 1999;18:524-8

  47. Jeffery HE, Lahra MM. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998;101:E2. URL: http://www.pediatrics.org/cgi/content/full/101/1e2.

  48. Jeffery HE, McIntosh ED. Antepartum screening and non- selective intrapartum chemoprophylaxis for group B streptococcus. Aus N Z J Obstet Gynaecol 1994;34:14-9.

  49. Kuruvilla KA, Thomas N, Jesudasan MV, Jana AK. Neonatal group B streptococcal bacteraemia in India: ten years’ experience. Acta Paediatr 1999;88:1031-2.

  50. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.

  51. Lim DV, Morales WJ, Walsh AF, Kazanis D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986;23:489-92.

  52. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991;40:57-62.

  53. Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999;181:816-21.

  54. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999;103;703-10.

  55. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of preventive strategies for neonatal group B streptococcal infection. A population-based  economic analysis. JAMA 1993;270:1442-8.

  56. Morales WJ, Dickey SS, Bornick P, Lim DV. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol 1999;181:310-4.

  57. Morales WJ, Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13-6.

  58. Morales WJ, Lim DV, Walsh AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986;155:979-83.

  59. Moses LM, Heath PT, Wilkinson AR, Jeffery HE, Isaacs D. Early onset group B streptococcal neonatal infection in Oxford 1985-96. Arch Dis Child 1998;79:148-9.

  60. Noya FJ, Rench MA, Metzger TG, Colman G et al. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987;155:1135-44.

  61. Ohlsson A, Myhr TL. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: A critical review of randomized controlled trials. Am J Obstet Gynecol 1994;170:910-7.

  62. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-61.

  63. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995;85:437-9.

  64. Poulain P, Betremieux P, Donnio PY, Proudhon JF, Karege G, Giraud JR. Selective intrapartum anti-bioprohylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries. Eur J Obstet Gynecol Reprod Biol 1997;72:137-40.

  65. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcomes of newborns. Pediatrics 1994;93:631-5.

  66. Regan JA, Klebanoff MA, Nugent RP et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354-60.

  67. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.

  68. Scharg SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.

  69. Schimmel MS, Eidelman AI, Rudensky B, Tadmor OP, Isacsohn M et al. Epidemiology of group B streptococcal colonization and infection in Jerusalem, 1989-1991. Isr J Med Sci 1994;30:349-51.

  70. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger  JD. Multistate case-control study of maternal risk factors for group B streptococcal  disease. The Active Surveillance Study Group. Pediatr Infect Dis J 1994;13:623-9.

  71. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, Broome CV. Population-based risk factors for neonatal group B streptococcal disease: Results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.

  72. Shah V, Ohlsson A. Perinatal group B streptococcal infections. In: Newell M-L, McIntyre J. Congenital and perinatal infections. Prevention, diagnosis and treatment. Cambridge University Press, Cambridge, 2000. Pp. 96-121.

  73. Silver HM, Struminsky J. A comparison of the yield of positive antenatal group B  streptococcus cultures with direct inoculation in selective growth medium versus  primary inoculation in transport medium followed by delayed inoculation in selective  growth medium. Am J Obstet Gynecol 1996;175:155-7.

  74. Society of Obstetricians and Gynaecologists of Canada, Canadian Pediatric Society.  National consensus statement on the prevention of early-onset group B streptococcal infections in the newborn. J Soc Obstet Gynaecol Can 1994;16:2271-8.

  75. Society of Obstetricians and Gynecologists. Statement on the prevention of early-onset group B streptococcal infections in the newborn. J Soc Obstet Gynaecol 1997;19:751-8.

  76. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998;17:499-503.

  77. Strickland DM, Yeomans ER, Hankins GD. Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4-8.

  78. Terry RR, Kelly FW, Gauzer C, Jeitler M. Risk factors for maternal colonization with group B beta-hemolytic streptococci. J Am Osteopath Assoc 1999;99:571-3.

  79. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-83.

  80. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:583-7.

  81. Tuppurainen N, Osterlund K, Hallman M. Selective intrapartum penicillin prophylaxis of early onset group B streptococcal disease. Pediatr Res 1986;20:403A.

  82. Woolf SH, Battista RN, Anderson GM, Logan AG, Wang E and other members of the Canadian Task Force on the Periodic Health Examination. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990;43:891-905.

  83. Yancey MK, Armer T, Clark P, Duff P. Assessment of rapid identification tests for genital  carriage of group B streptococci. Obstet Gynecol 1992;80:1038-47.

  84. Yancey MK, Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;83:367-71.

  85. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late  antenatal screening cultures in predicting genital group B streptococcal colonization at  delivery. Obstet Gynecol 1996;88:811-5.

  86. Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ, Beachler CW. The natural history of group B streptococcal colonization in the pregnant women and her offspring.  I. Colonization studies. Am J Obstet Gynecol 1980;137:34-8.

  87. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-7.

  88. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States,1990: report from a multistate active surveillance system. Mor Mortal Wkly Rep CDC Surveill Summ 1992;41;25-32.

Link to Published Recommendation Statement

Link to Full Technical Report (in pdf)

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Top of Page

CTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
Original Copyright © 2000 Canadian Medical Association.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: April 08, 2003